Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allient Inc. stock logo
ALNT
Allient
$31.03
+3.8%
$24.02
$16.91
$32.95
$525.31M1.39116,870 shs96,817 shs
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$5.96
+4.9%
$5.81
$3.91
$13.99
$410.11M1.58818,451 shs1.45 million shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$3.55
+8.6%
$2.55
$0.58
$4.04
$155.60M1.13190,160 shs252,945 shs
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$0.54
+7.0%
$0.63
$0.25
$1.40
$353.28M1.056.69 million shs7.52 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allient Inc. stock logo
ALNT
Allient
0.00%-6.24%+37.89%+16.36%+11.91%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
0.00%-6.89%-10.83%-4.70%-49.10%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
0.00%-1.21%+45.33%+15.96%+298.78%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
0.00%-4.77%-33.17%-39.34%+13.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allient Inc. stock logo
ALNT
Allient
2.8159 of 5 stars
1.33.01.70.04.12.52.5
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
2.1052 of 5 stars
3.52.00.00.03.41.70.0
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
1.4278 of 5 stars
2.03.00.00.02.22.50.6
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
1.9033 of 5 stars
3.80.00.00.02.70.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allient Inc. stock logo
ALNT
Allient
2.50
Moderate Buy$31.00-0.10% Downside
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
3.00
Buy$25.38325.76% Upside
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
4.00
Strong Buy$8.00125.35% Upside
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
3.50
Strong Buy$2.00270.37% Upside

Current Analyst Ratings Breakdown

Latest RPID, SENS, EYPT, and ALNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $26.00
5/8/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$35.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/10/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$2.00
4/9/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/6/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
3/6/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
3/5/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.00 ➝ $2.00
(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allient Inc. stock logo
ALNT
Allient
$516.06M1.02$4.52 per share6.86$15.52 per share2.00
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$56.04M7.32N/AN/A$5.66 per share1.05
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$29.65M5.25N/AN/A$2.78 per share1.28
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$23.68M14.92N/AN/A$0.07 per share7.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allient Inc. stock logo
ALNT
Allient
$24.10M$0.5935.2616.96N/A2.64%10.80%4.75%8/6/2025 (Estimated)
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$70.79M-$2.41N/AN/AN/A-226.57%-43.01%-31.63%8/6/2025 (Estimated)
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$52.47M-$1.03N/AN/AN/A-184.93%-48.05%-39.18%8/1/2025 (Estimated)
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/A

Latest RPID, SENS, EYPT, and ALNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million
5/7/2025Q1 2025
Allient Inc. stock logo
ALNT
Allient
$0.33$0.46+$0.13$0.21$125.00 million$134.62 million
5/7/2025Q1 2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$0.65-$0.65N/A-$0.65$8.84 million$24.50 million
3/5/2025Q4 2024
Allient Inc. stock logo
ALNT
Allient
$0.28$0.31+$0.03$0.18$119.72 million$122.01 million
3/5/2025Q4 2024
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$0.54-$0.64-$0.10-$0.64$11.02 million$11.60 million
3/3/2025Q4 2024
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$0.03-$0.12-$0.09N/AN/AN/A
2/28/2025Q4 2024
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.22-$0.22N/A-$0.22$8.20 million$8.22 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allient Inc. stock logo
ALNT
Allient
$0.120.39%+4.55%20.34%N/A
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/AN/AN/AN/AN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/AN/AN/AN/AN/A
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
N/AN/AN/AN/AN/A

Latest RPID, SENS, EYPT, and ALNT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.4%5/22/20255/22/20256/5/2025
3/5/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.51%3/20/20253/20/20254/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allient Inc. stock logo
ALNT
Allient
0.85
4.10
2.18
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/A
5.50
5.45
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/A
5.52
4.19
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
59.17
2.47
2.38

Institutional Ownership

CompanyInstitutional Ownership
Allient Inc. stock logo
ALNT
Allient
61.57%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
99.41%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
52.60%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
12.36%

Insider Ownership

CompanyInsider Ownership
Allient Inc. stock logo
ALNT
Allient
15.60%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
4.74%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
29.96%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allient Inc. stock logo
ALNT
Allient
1,95016.93 million14.22 millionOptionable
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
12068.81 million65.02 millionOptionable
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
20043.83 million29.95 millionNot Optionable
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
90654.22 million573.90 millionN/A

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allient stock logo

Allient NASDAQ:ALNT

$31.03 +1.15 (+3.85%)
Closing price 04:00 PM Eastern
Extended Trading
$31.48 +0.45 (+1.47%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

EyePoint Pharmaceuticals stock logo

EyePoint Pharmaceuticals NASDAQ:EYPT

$5.96 +0.28 (+4.93%)
Closing price 04:00 PM Eastern
Extended Trading
$5.96 +0.00 (+0.02%)
As of 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Rapid Micro Biosystems stock logo

Rapid Micro Biosystems NASDAQ:RPID

$3.55 +0.28 (+8.56%)
Closing price 04:00 PM Eastern
Extended Trading
$3.62 +0.07 (+1.97%)
As of 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Senseonics stock logo

Senseonics NYSE:SENS

$0.54 +0.04 (+6.99%)
Closing price 04:00 PM Eastern
Extended Trading
$0.54 +0.00 (+0.74%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.